Table of Contents
Influenza Research and Treatment
Volume 2011, Article ID 126794, 12 pages
http://dx.doi.org/10.1155/2011/126794
Research Article

A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection

1Department of Pathobiology and Veterinary Science, University of Connecticut, 61 North Eagleville Road, Storrs, CT 06268, USA
2Department of Molecular and Cell Biology, University of Connecticut, 91 North Eagleville Road, Storrs, CT 06269, USA
3The Institute of Materials Science, University of Connecticut, 97 North Eagleville Road, Storrs, CT 06269, USA
4M.E. Müller Institute, University of Basel, 50/70 Klingelbergstrasse, 4056 Basel, Switzerland
5Institute for Medical Microbiology, University of Basel, 4003 Basel, Switzerland
6Charles River SPAFAS, Inc., 106 RT 32 North Franklin, Storrs, CT 06254, USA
7Department of Statistics, University of Connecticut, 215 Glenbrook Road, Storrs, CT 06269, USA

Received 6 June 2011; Revised 24 September 2011; Accepted 12 October 2011

Academic Editor: Oleg P. Zhirnov

Copyright © 2011 Sankhiros Babapoor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sankhiros Babapoor, Tobias Neef, Christian Mittelholzer, et al., “A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection,” Influenza Research and Treatment, vol. 2011, Article ID 126794, 12 pages, 2011. https://doi.org/10.1155/2011/126794.